Survival outcomes
deaths, infections
EVENT, LUNG DISEASES, INFECTIONS
Cancer-specific deaths occurred in 22.6% of cases (N = 7230), whereas all-cause mortality exceeded 57.6% (N = 18,485) during the median follow-up of 116 months (IQR 80–153 months). The 5-year OS exceeded 58%. Noteworthy, 9028 patients, who were excluded from the prediction of 5-year CSS included those who were lost to follow-up (N = 2156; 6.7%) and those who died of other causes before 5 years of follow-up (cardiovascular diseases—2658 pts/ 8.3%; other cancer—1563 pts/4.9%; lung diseases and infections 759/2.3% and other mortality causes 1868 pts/5.8%). These exclusions were made due to competing event in the majority of cases and lost to follow-up in the minority. Comparison of included and excluded patients’ characteristics are shown in the supplementary table 1.